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Abstract
Purpose: The metaphase karyotype is often used as a diagnostic tool in the setting of early miscarriage; however this
technique has several limitations. We evaluate a new technique for karyotyping that uses single nucleotide polymorphism
microarrays (SNP). This technique was compared in a blinded, prospective fashion, to the traditional metaphase karyotype.
Methods: Patients undergoing dilation and curettage for first trimester miscarriage between February and August 2010
were enrolled. Samples of chorionic villi were equally divided and sent for microarray testing in parallel with routine
cytogenetic testing.
Results: Thirty samples were analyzed, with only four discordant results. Discordant results occurred when the entire
genome was duplicated or when a balanced rearrangement was present. Cytogenetic karyotyping took an average of 29
days while microarray-based karytoyping took an average of 12 days.
Conclusions: Molecular karyotyping of POC after missed abortion using SNP microarray analysis allows for the ability to
detect maternal cell contamination and provides rapid results with good concordance to standard cytogenetic analysis.
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Introduction
First trimester miscarriages are common among couples with up
to 20% of clinically recognized pregnancies ending in spontaneous
abortion [1–3]. These events are multifactorial; however, certain
risk factors are known to increase the risk of miscarriage. These
factors include older age, history of previous miscarriage,
substance exposure, maternal extremes of weight, delayed
ovulation to implantation interval, maternal systemic illness and
uterine anomalies. Despite a multitude of maternal factors that can
contribute to miscarriage, the majority (50–60%) of first trimester
miscarriages are due to fetal chromosomal abnormalities [4].
Whereas chromosomal testing of products of conception (POC)
is not recommended for every miscarriage, there are many
scenarios where knowing the chromosome status of a miscarried
fetus can help in clinical management. It can be particularly
helpful in the recurrent pregnancy loss and infertility populations.
The most common method of testing is a metaphase karyotype,
which is available through the cytogenetics department in most
hospitals [5]. This method is considered the gold standard for
chromosome analysis but has three practical limitations. First, a
successful cell culture is required but failure occurs in 10–40% of
cases (6). Second, the results take approximately 4–6 weeks. And
third, if the results suggest normal female karyotype (46,XX), a
result that happens 55–80% of the time, it is unknown whether the
tested sample was of fetal or maternal in origin [6].
We evaluate here, in a blinded, head-to-head fashion, a new
informatics enhanced technique that uses genotypic data of both
the POC sample and the mother, measured with single nucleotide
polymorphism (SNP) microarrays, to detect the number of copies
of all 24 chromosomes simultaneously [7]. These arrays afford
faster turnaround time and when combined with the Parental
Support
TM algorithm are able to determine parental source of
chromosomes and abnormalities. Minimal tissue is required for
karyotype analysis using SNP microarrays and the technology is
able to confidently differentiate between maternal and fetal
chromosomes in case of 46,XX.
The objective of this study is to examine the efficiency and
accuracy of the informatics based technique in combination with
single nucleotide polymorphism microarrays on products of
conception after first trimester miscarriage in a prospective cohort.
Materials and Methods
This study was approved by the Stanford University Institu-
tional Review Board and all subjects gave written and verbal
consent to participate. Couples treated at an academic reproduc-
tive endocrinology and infertility practice with a documented
intrauterine pregnancy loss between February 2010 and August
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parents were available to give DNA samples and desired
chromosome testing of the miscarried tissue.
A missed abortion was diagnosed by transvaginal ultrasound
and confirmed by repeat ultrasound prior to the dilation and
curettage (D&C) procedure [8]. Suction curettage was performed
in usual fashion under ultrasound guidance. Chorionic villi were
separated from maternal deciduas via a standardized technique
[9]. Once chorionic villi were separated and cleaned, the specimen
was divided into equal samples and sent for microarray testing in
parallel with routine cytogenetic testing.
Thirty samples were analyzed by both microarray and
traditional cytogenetics. The mean age of women was 37.2 years
old; range 29–41 years. Mean maternal body mass index (BMI)
was 26.7 kg/m
2; range 20–32. Table 1 includes all demographic
data from the study population. The mean gestational age at time
of D&C was 8.75 weeks; with a range 7–12 weeks; 27% of
pregnancies were spontaneous conceptions whereas 73% were
conceived using assisted reproductive technologies (33% intra-
uterine insemination (IUI), 37% in vitro fertilization (IVF), and
3% IVF with donor egg).
Genotyping of the maternal and POC samples was performed
at a commercial reference lab using Illumina CytoSNP-12
genotyping microarrays, which measure approximately 300,000
SNPs across the genome, (roughly one every 10 kb) according to
the manufacturer’s instructions. After a genomic sample is run on
a SNP array the results must pass a rigorous in-house quality
control test before further analysis is done. The informatics
technique (Parental Support
TM), using the output of the SNP
arrays, determined the number and origin of each of the
chromosomes in the POC sample.
In order to determine the chromosome copy number, the
informatics technique compares, for each SNP on a given
chromosome, the intensity of the signal from each of two possible
alleles. The relative intensities have a statistical distribution that is
indicative of the number of copies of that chromosome. Each
analyzed sample produces 24 images, one for each chromosome,
and the chromosome number is determined for each chromosome
based on the image produced. Whereas the majority of
chromosomes will be disomic as in Figure 1b, abnormalities such
as monosomy, trisomy, segmental additions or deletions will
appear clearly different from disomic chromosomes. Triploidy is
detected when all chromosomes are trisomic. The images in
Figure 1 are for individual chromosomes graphically illustrating
different ploidy states; each plot represents one chromosome, and
each dot represents one SNP. The x-axis is the SNP location along
the chromosome, and the y-axis is the relative intensity of the two
allelic measurements at that SNP. SNPs that are homozygous are
found either at the top or the bottom of the plot, While snps that
are heterozygous are toward the center of the plot.
In the case of a monosomy (Fig. 1a), alleles are all homozygous
so we only see the top and bottom cluster. In the case of a disomy
(Fig. 1b), we see the two sets of homozygous alleles at the top and
bottom, and also the set of heterozygous alleles in the middle. In
the case of a trisomy (Fig. 1c), we see the two sets of homozygous
alleles plus two sets of heterozygous alleles (AAB and ABB).
Figure 1d shows an example of a partial duplication.
Routine cytogenetic testing consisted of cell culture and analysis
by the Giemsa-trypsin-wrights banding methods by a university
reference lab. Chorionic villi from a miscarriage were grown in
culture, the cells were then arrested and Giemsa used to stain
bands in the chromosomes to allow for visualization and
identification, known as G-banding.
Results
Overall, 63% of karyotyped POC were chromosomally
abnormal on routine cytogenetics. The mean maternal age at
the time of miscarriage was 37.2 years and the mean gestational
age at the time of uterine evacuation was 8.75 weeks (see Table 1
for patient characteristics). The majority of abnormalities were due
to autosomal trisomies (15 out of 19) and, not surprisingly, 14 of 15
of these were due to excess maternal chromosomes. In addition to
the autosomal trisomies, there were two unbalanced translocations
(one inherited and one de novo). There was one triploidy and one
tetraploidy in our data set. All 46,XX results from cytogentics were
confirmed to be POC samples as microarray analysis clearly
detected one maternal and one paternal copy of each chromo-
some, ruling out maternal contamination. The cytogenetic
karyotyping took, on average, 29 days to return results. In
contrast, the microarray based karyotyping took 12 days for the
initial research samples. The last eight microarray samples, run in
a production setting, averaged only 7 days for turn around.
The chromosome results of the 30 samples from each of the 2
techniques are shown in Table 2. Of the 30 samples, four results
were discordant between the cytogenetic and microarray tech-
niques, giving a concordance of 87% between the two techniques.
In one case, cytogenetic karyotyping returned a 92,XXXX result,
while the informatics technique found 46,XX. In a second case,
cytogenetics reported a 46,XY,+15,der(15;15)(q10;q10) karyotype,
while the informatics technique returned a result of trisomy 15. In
a third case, cytogenetics found trisomy 22, while the informatics
technique found maternal cell contamination (testing separate
samples from the same case). In the last case, the cytogenetics
reported a 46, X, +22 karyotype, while the informatics technique
reported 47,XX, +22.
Table 1. Demographic data.
a
Maternal Age (yr) 37.2 (29–41)
Paternal Age 37.9 (30–49)
Maternal BMI 26.7 (20–32)
Mode of conception
Spontaneous 27%
IUI 33%
IVF 37%
Donor oocyte 3%
Gestational age at time of D&C (wks) 8.75 (7–12)
Maximum CRL achieved (mm)
b 12 (6–29)
Prior live births
06 7 %
13 0 %
23 %
Prior miscarriages
04 6 %
12 0 %
21 7 %
3 or more 17%
aResults expressed as mean and range, with exceptions noted.
bIn 10 of the 30 cases, no fetal pole was present, with only a gestational sac
visualized on ultrasound.
doi:10.1371/journal.pone.0031282.t001
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explained by the known limitation of quantitative genetics and
their inability to detect whole genome duplication and balanced
structural rearrangements. However, only one would be consid-
ered a false negative result (meaning that the reported result was
normal non-maternal when the true karyotype of the POC was
tetraploid). The missed unbalanced structural rearrangement was
reported as abnormal and lethal. In this case the parental
karyotypes were normal and the translocation was considered
denovo, and no more likely to recur than a denovo aneuploidy.
The latter two cases of discrepancies illustrate a limitation of the
study. Although the samples analyzed by the two methods came
from the same procedure, the tissue sample analyzed was different
and, therefore, the discrepancies can be explained by sampling
error, tissue mosaicism, or culture artifact. Again, in the case or
trisomy 22 with or without monosomy X, the patient would be
counseled the same and no further evaluation for maternal causes
of miscarriage are indicated.
Discussion
The application of informatics and microarray technology to
analysis of miscarriage tissues gives fetal karyotype results in
significantly less time than routine cytogenetic testing, and avoids
the potential pitfalls of cell culture. While array comparative
genomic hybridization (aCGH) has been reported in this context
[10,11], to our knowledge, this is the first application of SNP
microarray technology to determining the karyotype of POC
samples. The use of the informatics enhanced SNP microarray
technique gives us additional information about parental source of
aneuploidy, enables detection of uniparental disomy (UPD), and is
able to differentiate POC from maternal DNA in the setting of a
46,XX result.
Although definitive testing is not routinely done in the case of a
46,XX result, studies show that maternal contamination is present
in 29–58% of cases where 46,XX is reported with routine
cytogenetics [6]. In a study by Robberecht et al, 105 miscarriages
were studied with both conventional cytogenetics and a CGH.
Although they were able to identify 7 cases of likely MCC due to
discrepancies between cytogenetic and aCGH, there were still a
significant excess of 46,XX cases detected by both methods (37
cases of 46,XX compared to 4 cases of 46,XY) [12]. The excess
was attributed to maternal contamination, though not confirmed
with any molecular markers. The inability to trust a 46,XX result
leads the patient and provider to either disregard the information
given or conclude the miscarriage was chromosomally normal
when this may or may not be an accurate reflection of the
miscarriage. Being able to differentiate maternal contamination
from a chromosomally normal female improves the accuracy of
this test significantly.
Figure 1. Graphic illustration of data for individual chromosome with different chromosome copy number a) monosomy 21, b)
disomy 6, c) trisomy 16, d) partitial duplication chromosome 7.
doi:10.1371/journal.pone.0031282.g001
Table 2. Karyotype results of 30 cases analyzed by both SNP
micro arrays and cytogenetics.
Abnormalities Detected SNP micro array cytogenetics
Single Autosomal Trisomies* 14 14
Double trisomy 2 2
Triploidy 69,XXY 1 1
Tetraploidy 92,XXXX 0 1
Unbalanced translocation** 1 2
MCC 1 0
Normal 46,XX non-maternal 9 8
Normal 46,XY 2 2
*Autosomal Trisomies identified (2,3,13,14,15,16,18,20,22).
**One unbalanced translocation detected by both methods 46,XX, der
(14)t(3;14)(p21;q32)mat.
One unbalanced robertsonian translocation 46,XY,+15,der(15;15)(q10;q10) was
reported as trisomy 15 by SNP micro array.
doi:10.1371/journal.pone.0031282.t002
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limitations compared to cytogenetic karyotyping: (a) it cannot
detect errors due to duplication of the entire genome, and (b) it
cannot detect balanced structural rearrangements. On the other
hand, the informatics enhanced microarray method described
herein can detect errors where the identities of chromosomes are
wrong, e.g. UPD, a condition that other technologies such as
fluorescence in situ hybridization (FISH), aCGH, and cytogenetic
karyotyping cannot detect. Two of the discordant results illustrate
the two limitations of the microarray informatics based technique:
(a) it did not detect a 2:2 tetraploidy; and (b) nor did it detect a
Robertsonian translocation.
Tetraploidy is found in 2% of POC samples [4] and can be
classified into two categories: the more common type, 2:2
tetraploidy, is where each parent contributes a full extra set of
chromosomes for a total of 2 identical sets from the mother and 2
identical sets from the father, and is likely due to failure of
cytokinesis at all of the chromosomes. The less common, 3:1
tetraploidy, is where 3 sets of chromosomes are from one parent
and 1 is from the other, and has a more complicated origin. SNP
microarrays are able to detect triploidy (3 chromosome sets) due to
their genotyping ability, and when using the informatics technique
used in this study, able to detect 3:1 tetraploidy. However
detection of multiples of entire chromosome sets, such as 2:2
tetraploidy or 3:3 hexaploidy, remains a limitation of the
technology. These types of abnormalities can be detected with
traditional cytogenetic karyotyping, or with microarray techniques
used in combination with flow cytometry, or FISH [12–14].
Errors involving structural chromosome rearrangement, such as
balanced translocations and Robertsonian translocations, are
found in approximately 0.5% of POC samples [15]. Note that a
Robertsonian translocation is formally a balanced translocation,
although in practice, the complementary chromosome made up of
the two tiny p-arms found in acrocentric chromosomes is often lost
after a few rounds of mitosis. The inability to detect balanced
chromosomal structural rearrangements, or differentiate between
actual trisomy due to three separate copies of the chromosome
versus a specious trisomy resulting from an isochromosome or
Robertsonian translocation, is a limitation inherent to all
microarray testing [16]. These types of abnormalities can only
be detected with traditional cytogenetic techniques where the
chromosome itself and banding pattern can be viewed. A balanced
translocation is not lethal and, therefore, would not be expected to
cause a miscarriage. If the genetic material is not balanced, then
the array would be able to identify any unbalanced karyotype.
Couples at risk for having balanced structural rearrangements in
either parent should undergo routing cytogentic analysis of
peripheral blood to accurately identify whether a translocation is
present.
These two limitations are potentially clinically relevant since
they can result in misdiagnosis of ploidy state in the event of 2:2
tetraploidy, or, erroneous recurrence risk for subsequent miscar-
riage if a trisomy occurred due to an inherited unbalanced
Robertsonian translocation when the presumption was pure
trisomy. However, options exist for addressing these limitations.
Trisomic results involving the acrocentric chromosomes (13, 14,
15, 21, 22) can be followed up with parental karyotyping. If a
trisomy of an acrocentric chromosome is found with a microarray,
the possibility or an isochromosome or balanced Robertsonian
translocation in a parent exists. Therefore, providers are advised to
proceed with parental karyotype if there is a clinical indication,
such as infertility or recurrent pregnancy loss, because it has the
potential to impact patient care and prognosis. An advantage of
the informatics technique is the ability to determine the parental
source of aneuploidy, enabling karyotyping to be done only on the
parent of origin. To address tetraploidy, reflex testing of normal
results with two-probe FISH would enable confirmation or
detection of tetrasomic state leading to a conclusion of tetraploidy.
The other two discordant results are likely due to discordant
samples. The case of maternal cell contamination is surprising only
in that of sixty biopsies (samples from 30 study subjects 62); only
one was contaminated with maternal cells. Note: this includes
eight cases of 46,XX as called by cytogenetic karyotyping, which
were confirmed as genuine 46,XX by the microarray informatics
technique. The final discordance was due to a finding of 46,X,+22
by cytogenetics, and a finding of 47,XX,+22 by the informatics
technique. This may be due to a culturing artifact that resulted in a
dropped chromosome in the cytogenetic sample, or to mosaicism
in the POC sample, rather than testing error since the microarray
informatics result delivered exceptionally clean data illustrating
two distinct genotypes [see Fig. 1b]. The finding of discrepant
results involving complex aneuploidies between cytogenetic and
molecular methods (aCGH) have been previously reported and
may be as high as 50% [15]. Here the authors postulate an
alternative explanation of placental mosaicism that is revealed
through analysis of direct versus cultured chorionic villi [17].
Though interesting, these discrepancies are not clinically
significant in terms of misdiagnosis or incorrect prognosis. A
46,X,+22 and a 47,XX,+22 are both aneuploid and associated
with the same clinical conclusion, and a finding of maternal
contamination is simply interpreted as non-fetal.
Since the two types of aneuploidy that the informatics based
technique can not detect typically account for approximately 3%
of POC cases, this indicates that this technique should, in theory,
be roughly concordant with 97% of the results from cytogenetic
karyotyping, making the strong assumption of no cell culture
artifacts or other errors during cytogenetic karyotyping. In this
study, the concordance rate was 87% (26/30), with the clinically
relevant concordance rate being 93% (28/30). The clinically
relevant concordance was defined as differences in molecular
karyotype and routine karyotype that would change how patients
were counseled about the cause of their miscarriage. Given the
small sample size of this study, we would expect the concordance
to be higher with larger numbers as tetraploidy and Robersonian
translocations are rare but both occurred in our sample.
All diagnostic tests have their advantages and disadvantages.
Therefore, physicians must weigh the pros and cons of different
testing options to counsel patients on their test options and results.
Maternal cell contamination is a significant problem in POC
diagnosis, and can often lead to spurious conclusions. The use of
the careful tissue separation techniques, as previously described,
can bring down the rate of MCC in POC samples dramatically,
but maternal cell contamination can still occur [9]. Use of the SNP
arrays combined with an informatics based technique such as the
one described herein can identify fetal and maternal tissue,
removing the uncertainty associated with MCC. Rates of culture
failure and maternal contamination likely vary at different centers.
If a physician encounters high culture failure rates (.5%) or
disproportionately high numbers of 46,XX results with routine
cytogenetics, he or she may consider molecular karyotyping with
SNP arrays as a first line. However, there are some relatively rare
abnormalities that can be missed, such as 2:2 tetraploidy and
robertsonian translocations and physicians using SNP microarrays
should be aware of these.
Patients go though significant grieving after a miscarriage and
knowing the results of the chromosomal analysis sooner may help
patients understand the cause of their loss and begin planning for
future pregnancy attempts. The informatics based technique
SNP Microarray Analysis of Miscarriage Samples
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e31282described herein can bring the turn-around time of karyotyping
from one month to less than a week. The benefits of rapid
turnaround, the ability to definitively detect maternal contamina-
tion, the elimination of cell culture and its associated problems,
justify the continued exploration and clinical application of this
technology for analyzing products of conception.
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